Center for Clinical Research, Falun Uppsala University, Uppsala, Sweden.
Gynecol Oncol. 2011 Aug;122(2):372-6. doi: 10.1016/j.ygyno.2011.04.049. Epub 2011 May 31.
Novel biological markers LRIG1 and LRIG2 have been associated with favorable as well as poor prognosis, respectively, in different cancer types, including cervical cancer. The aim of this study was to investigate possible interactions between these proteins and other tumor markers, and as diagnostic adjuncts in CIN.
Cervical biopsies from 171 women, with normal epithelium, and low-grade and high-grade CIN were stained for LRIG1 and LRIG2, and 11 additional tumor markers. The tumor markers were chosen to be relevant in cervical neoplasms. Staining was evaluated semiquantitatively.
Expression of LRIG1 and LRIG2 was found to correlate with increasing CIN grade, as well as with expression of tumor suppressor FHIT, independent of histological grade. In addition, tumor promoter LRIG2 expression correlated negatively with expression of tumor suppressor retinoblastoma protein and positively with IL-10. The latter correlation did not however remain after adjustment for CIN grade. p53 and p16 expressions correlated positively with LRIG1 expression in univariate analyses, but significance did not hold after adjustment for CIN grade.
LRIG1 and LRIG2 expressions were seen in precancerous cervical epithelium and found to increase with increasing grade. There was an association between expression of these glycoproteins and FHIT tumor suppressor protein, independently of histological grade.
LRIG1 和 LRIG2 这两种新型生物标志物分别与不同癌症类型(包括宫颈癌)的预后良好和不良相关。本研究旨在探讨这些蛋白与其他肿瘤标志物之间的可能相互作用,并作为 CIN 的诊断辅助手段。
对 171 名女性的宫颈活检组织进行 LRIG1 和 LRIG2 以及其他 11 种肿瘤标志物的染色。选择与宫颈癌相关的肿瘤标志物进行染色。采用半定量方法进行评估。
LRIG1 和 LRIG2 的表达与 CIN 分级的增加以及肿瘤抑制因子 FHIT 的表达相关,而与组织学分级无关。此外,肿瘤促进因子 LRIG2 的表达与肿瘤抑制因子视网膜母细胞瘤蛋白的表达呈负相关,与 IL-10 的表达呈正相关。然而,这种相关性在调整 CIN 分级后并不成立。p53 和 p16 的表达与 LRIG1 的表达在单变量分析中呈正相关,但在调整 CIN 分级后,其意义并不存在。
LRIG1 和 LRIG2 在癌前宫颈上皮中表达,并随着分级的增加而增加。这些糖蛋白的表达与 FHIT 肿瘤抑制蛋白之间存在关联,而与组织学分级无关。